| Year |
Citation |
Score |
| 2020 |
Andrews CD, Huang Y, Ho DD, Liberatore RA. In Vivo Expressed Biologics for Infectious Disease Prophylaxis: Rapid Delivery of DNA-Based Antiviral Antibodies. Emerging Microbes & Infections. 1-32. PMID 32579067 DOI: 10.1080/22221751.2020.1787108 |
0.337 |
|
| 2017 |
Andrews CD, Luo Y, Sun M, Yu J, Goff AJ, Glass PJ, Padte NN, Huang Y, Ho DD. In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections. Molecular Therapy. Methods & Clinical Development. 7: 74-82. PMID 29034261 DOI: 10.1016/J.Omtm.2017.09.003 |
0.311 |
|
| 2016 |
Song R, Pace C, Seaman MS, Fang Q, Sun M, Andrews CD, Wu A, Padte NN, Ho DD. Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies. Journal of Acquired Immune Deficiency Syndromes (1999). 73: 365-373. PMID 27792681 DOI: 10.1097/Qai.0000000000001119 |
0.356 |
|
| 2016 |
Huang Y, Yu J, Lanzi A, Yao X, Andrews CD, Tsai L, Gajjar MR, Sun M, Seaman MS, Padte NN, Ho DD. Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity. Cell. 165: 1621-1631. PMID 27315479 DOI: 10.1016/J.Cell.2016.05.024 |
0.374 |
|
| 2016 |
Lanzi A, Huang Y, Yu J, Yao X, Andrews CD, Tsai L, Gajjar MR, Seaman MS, Padte NN, Ho DD. 10E8V2.0/iMab: an engineered membrane-anchored bispecific anti-HIV antibody effective in preventing and treating HIV in humanized mice Journal of Virus Eradication. 2: 17-18. DOI: 10.1016/S2055-6640(20)31105-5 |
0.329 |
|
| 2015 |
Andrews CD, Heneine W. Cabotegravir long-acting for HIV-1 prevention. Current Opinion in Hiv and Aids. 10: 258-63. PMID 26049951 DOI: 10.1097/Coh.0000000000000161 |
0.324 |
|
| 2015 |
Andrews CD, Yueh YL, Spreen WR, St Bernard L, Boente-Carrera M, Rodriguez K, Gettie A, Russell-Lodrigue K, Blanchard J, Ford S, Mohri H, Cheng-Mayer C, Hong Z, Ho DD, Markowitz M. A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge. Science Translational Medicine. 7: 270ra4. PMID 25589630 DOI: 10.1126/Scitranslmed.3010298 |
0.355 |
|
| 2014 |
Andrews CD, Spreen WR, Mohri H, Moss L, Ford S, Gettie A, Russell-Lodrigue K, Bohm RP, Cheng-Mayer C, Hong Z, Markowitz M, Ho DD. Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus. Science (New York, N.Y.). 343: 1151-4. PMID 24594934 DOI: 10.1126/Science.1248707 |
0.345 |
|
| 2013 |
Padte NN, Boente-Carrera M, Andrews CD, McManus J, Grasperge BF, Gettie A, Coelho-dos-Reis JG, Li X, Wu D, Bruder JT, Sedegah M, Patterson N, Richie TL, Wong CH, Ho DD, et al. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. Plos One. 8: e78407. PMID 24205224 DOI: 10.1371/Journal.Pone.0078407 |
0.35 |
|
| 2013 |
Pace CS, Song R, Ochsenbauer C, Andrews CD, Franco D, Yu J, Oren DA, Seaman MS, Ho DD. Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 110: 13540-5. PMID 23878231 DOI: 10.1073/pnas.1304985110 |
0.316 |
|
| 2012 |
Andrews CD, Huh MS, Patton K, Higgins D, Van Nest G, Ott G, Lee KD. Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity. Molecular Pharmaceutics. 9: 1118-25. PMID 22376145 DOI: 10.1021/Mp2003835 |
0.324 |
|
| 2011 |
Andrews CD, Provoda CJ, Ott G, Lee KD. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation. Bioconjugate Chemistry. 22: 1279-86. PMID 21612239 DOI: 10.1021/Bc100436Y |
0.315 |
|
| 2008 |
Kamrud KI, Alterson KD, Andrews C, Copp LO, Lewis WC, Hubby B, Patel D, Rayner JO, Talarico T, Smith JF. Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats. Plos One. 3: e2709. PMID 18628938 DOI: 10.1371/Journal.Pone.0002709 |
0.314 |
|
| Show low-probability matches. |